Screening and bioinformatics analysis of lung cancer exhale breath biomarkers

被引:1
|
作者
Wu Q. [1 ]
Wang P. [1 ]
机构
[1] Key Laboratory for Biomedical Engineering of Education Ministry, Zhejiang University, Hangzhou
来源
Zhejiang Daxue Xuebao (Gongxue Ban)/Journal of Zhejiang University (Engineering Science) | 2019年 / 53卷 / 12期
关键词
Bioinformatics; Early screening of lung cancer; Exhale breath detection; Lung cancer biomarker; Protein structure analysis; Transcriptome analysis;
D O I
10.3785/j.issn.1008-973X.2019.12.017
中图分类号
学科分类号
摘要
The exhale breath detection combined bioinformatics analysis method, including transcriptome, metabolic pathway and protein structure, was proposed to identify gas markers for screening and diagnosis of lung cancer. Lung cancer patients and healthy controls' samples were collected to performe GC-MS and ROC curve analysis which obtained ten specific VOCs. Differentially expressed genes were obtained by transcriptome analysis. The differentially expressed genes and relative metabolic pathways were consistent with in vivo biological process, which meant that these VOCs come from the metabolism of lung cancer patient. The sensitivity, specificity and overall accuracy of lung cancer diagnosis model established based on VOCs were 86.2%, 91.2% and 89.6%, respectively. Thus, the proposed method can distinguish normal people and lung cancer patients simply and effectively, providing convenient approach for early screening of lung cancer. © 2019, Zhejiang University Press. All right reserved.
引用
收藏
页码:2389 / 2395
页数:6
相关论文
共 26 条
  • [1] Chen X., Xu F., Wang Y., Et al., A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis, Cancer, 110, 4, pp. 835-844, (2007)
  • [2] Wang Y., Hu Y., Wang D., Et al., The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines, Cancer Biomarkers, 11, 4, pp. 129-137, (2012)
  • [3] Hakim M., Broza Y.Y., Barash O., Et al., Volatile organic compounds of lung cancer and possible biochemical pathways, Chemical Reviews, 112, 11, pp. 5949-5966, (2012)
  • [4] Tomczak K., Czerwinska P., Wiznerowicz M., The cancer genome atlas (TCGA): an immeasurable source of knowledge, Contemporary Oncology, 19, 1, pp. A68-A77, (2015)
  • [5] Li T., Kung H.J., Mack P.C., Et al., Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies, International Journal of Clinical Oncology, 31, 8, pp. 1039-1049, (2013)
  • [6] Comprehensive genomic characterization of squamous cell lung cancers, Nature, 489, 7417, pp. 519-525, (2012)
  • [7] Vogelstein B., Papadopoulos N., Velculescu V.E., Et al., Cancer genome landscapes, Science, 339, 6127, pp. 1546-1558, (2013)
  • [8] Zou Y., Zhang X., Chen X., Et al., Optimization of volatile markers of lung cancer to exclude interferences of non-malignant disease, Cancer Biomarkers, 14, 5, pp. 371-379, (2014)
  • [9] Park S.H., Goo J.M., Jo C.H., Receiver operating characteristic (ROC) curve: practical review for radiologists, Korean Journal of Radiology, 5, 1, pp. 11-18, (2004)
  • [10] Mccarthy D.J., Chen Y., Smyth G.K., Differential expression analysis of multifactor RNASeq experiments with respect to biological variation, Nucleic Acids Research, 40, 10, pp. 4288-4297, (2012)